Chromosome abnormalities may correlate with prognosis in Burkitt/Burkitt-like lymphomas of children and adolescents - A report from children's cancer group study CCG-E08

被引:46
作者
Lones, MA
Sanger, WG
Le Beau, MM
Heerema, NA
Sposto, R
Perkins, SL
Buckley, J
Kadin, ME
Kjeldsberg, CR
Meadows, A
Siegel, S
Finlay, J
Bergeron, S
Cairo, MS
机构
[1] Childrens Oncol Grp, Operat Ctr, Arcadia, CA 91066 USA
[2] St Joseph Hosp, Childrens Hosp Orange Cty, Dept Pathol, Orange, CA USA
[3] Univ Nebraska, Ctr Med, Ctr Human Genet, Omaha, NE 68182 USA
[4] Univ Chicago, Hematol Oncol Sect, Chicago, IL 60637 USA
[5] Childrens Hosp, Dept Cytogenet, Columbus, OH 43205 USA
[6] Ohio State Univ, Columbus, OH 43210 USA
[7] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA USA
[8] Univ Utah, Ctr Hlth Sci, Dept Pathol, Salt Lake City, UT USA
[9] Univ So Calif, Dept Prevent Med, Los Angeles, CA 90089 USA
[10] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA
[11] Harvard Univ, Sch Med, Boston, MA 02115 USA
[12] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA
[13] Childrens Hosp Los Angeles, Div Hematol Oncol, Los Angeles, CA 90027 USA
[14] NYU, Ctr Med, Hassenfeld Childrens Ctr, Dept Hematol Oncol, New York, NY USA
[15] Columbia Univ, Childrens Hosp New York Presbyterian, Dept Pediat, New York, NY USA
关键词
non-Hodgkin lymphoma; B-cell lymphoma small noncleaved-cell lymphoma; chromosomes; cytogenetic analysis; karyotyping; chromosome banding; chromosome aberrations; child adolescence;
D O I
10.1097/00043426-200403000-00006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Among pediatric non-Hodgkin lymphomas, the most frequent type is small noncleaved-cell lymphoma (including Burkitt and Burkitt-like). Specific chromosome abnormalities are associated with prognosis in childhood acute lymphoblastic leukemia (ALL); however, chromosome abnormalities have not been evaluated for prognostic value in pediatric Burkitt and Burkitt-like lymphomas. For Children's Cancer Group protocol CCG-E-08 Etiologic Study of Non-Hodgkin Lymphoma in Childhood, 19 patients were enrolled with cytogenetic analysis of Burkitt or Burkitt-like lymphoma and simultaneously enrolled on treatment protocols CCG-503 or CCG-552. Pathology material and karyotypes at initial diagnosis underwent central review. Demographics included an age range of 2 to 14 years (median 8 years) and a male:female ratio of 14:5. All patients had advanced disease (stages III and IV, or ALL). Disease relapsed in five patients (event-free survival 74%, median follow-up 10.4 years). Chromosome abnormalities were identified in 18 patients (95%) including t(8; 14)(q24.1;q32) in 12 (63%); t(8;22)(q24.1;q 11.2) in 1 (5%); partial duplication of 1 q in 7 (37%); and 13q32 abnormalities in 2 (11%). In patients who had relapses, in addition to the t(8; 14)(q24.1;q32), two had abnormalities of 13q32 and two had partial duplication of 1q. CMYC translocations were absent in Burkitt-like lymphomas from all three patients. Burkitt and Burkitt-like lymphomas in children have a high frequency of chromosome abnormalities. Burkitt lymphoma abnormalities often involve CMYC translocations, usually a t(8; 14)(q24.1;q32). Additional chromosome abnormalities that involved 13q32 and partial duplication of I q were associated with poor prognosis. Burkitt-like lymphomas were not associated with CMYC translocations. Further studies are warranted in larger cohorts of children and adolescents with Burkitt and Burkitt-like lymphomas.
引用
收藏
页码:169 / 178
页数:10
相关论文
共 42 条
  • [21] *KALBFLEISCH J, 1980, STAT ANAL FAILURE TI
  • [22] KORTH MJ, 1996, GENOMICS, V3, P238
  • [23] LAI JL, 1989, ANN GENET-PARIS, V32, P26
  • [24] Treatment of children and young adults with early-stage non-Hodgkin's lymphoma
    Link, MP
    Shuster, JJ
    Donaldson, SS
    Berard, CW
    Murphy, SB
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (18) : 1259 - 1266
  • [25] Small noncleaved, non-Burkitt's (Burkitt-like) lymphoma: Cytogenetics predict outcome and reflect clinical presentation
    Macpherson, N
    Lesack, D
    Klasa, R
    Horsman, D
    Connors, JM
    Barnett, M
    Gascoyne, RD
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (05) : 1558 - 1567
  • [26] SIMILAR EFFICACY OF 6 AND 18 MONTHS OF THERAPY WITH 4 DRUGS (COMP) FOR LOCALIZED NON-HODGKINS LYMPHOMA OF CHILDREN - A REPORT FROM THE CHILDRENS CANCER STUDY-GROUP
    MEADOWS, AT
    SPOSTO, R
    JENKIN, RDT
    KERSEY, JH
    CHILCOTE, RR
    SIEGEL, SE
    COCCIA, PF
    ROSENSTOCK, J
    PRINGLE, KC
    STOLAR, CJ
    KADIN, ME
    HAMMOND, GD
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (01) : 92 - 99
  • [27] MITELMAN F, 1995, 1995 INT SYSTEM HUMA
  • [28] MURPHY SB, 1980, SEMIN ONCOL, V7, P332
  • [29] The Societe Francaise d'Oncologie Pediatrique LMB89 protocol:: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia
    Patte, C
    Auperin, A
    Michon, J
    Behrendt, H
    Leverger, G
    Frappaz, D
    Lutz, P
    Coze, C
    Perel, Y
    Raphaël, M
    Terrier-Lacombe, MJ
    [J]. BLOOD, 2001, 97 (11) : 3370 - 3379
  • [30] RAIMONDI SC, 1993, BLOOD, V81, P2237